Shuttle Pharmaceuticals Holdings (SHPH) Accounts Payables (2021 - 2026)

Shuttle Pharmaceuticals Holdings has reported Accounts Payables for 6 years, with the latest figure at $1.8 million in Q1 2026.

• On a quarterly basis, Accounts Payables rose 99.55% year-over-year to $1.8 million in Q1 2026; TTM through Mar 2026 was $1.8 million, a 99.55% increase from a year earlier, with the FY2025 full-year figure at $1.5 million, up 143.68% from the prior year.
• Accounts Payables was $1.8 million for Q1 2026 at Shuttle Pharmaceuticals Holdings, up from $1.5 million in the prior quarter.
• The five-year high for Accounts Payables was $1.8 million in Q1 2026, with the low at $88741.0 in Q2 2023.
• Average Accounts Payables over 5 years is $711207.4, with a median of $447474.0 recorded in 2023.
• The sharpest annual moves came in 2022 and 2024: Accounts Payables sank 85.91% in 2022, then surged 649.14% in 2024.
• Over 5 years, Accounts Payables stood at $116745.0 in 2022, then surged by 142.29% to $282860.0 in 2023, then jumped by 110.92% to $596600.0 in 2024, then soared by 143.68% to $1.5 million in 2025, then climbed by 23.11% to $1.8 million in 2026.
• The last three Accounts Payables figures came in at $1.8 million (Q1 2026), $1.5 million (Q4 2025), and $1.5 million (Q3 2025), per Business Quant data.